Photodynamic therapy for superficial bladder cancer under local anaesthetic

Objectives To evaluate the use of local anaesthesia (LA) in 5‐aminolaevulinic acid (ALA) photodynamic therapy (PDT) for superficial transitional cell carcinoma (TCC) of the bladder, and to provide further toxicity and tolerability data on this new method within the context of a phase 1 trial.

[1]  U. Nseyo,et al.  Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. , 1987, The New England journal of medicine.

[2]  Q. Peng,et al.  5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.

[3]  R Baumgartner,et al.  Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.

[4]  C. Fowler,et al.  Urodynamic changes during therapeutic intravesical instillations of capsaicin. , 1996, British journal of urology.

[5]  U. Nseyo,et al.  Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. , 1998, Journal of clinical laser medicine & surgery.

[6]  N. Miyoshi,et al.  Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: a preliminary report. , 1984, The Journal of urology.

[7]  F. Hetzel,et al.  CLINICAL LASER PHOTODYNAMIC THERAPY IN THE TREATMENT OF BLADDER CARCINOMA , 1987, Photochemistry and photobiology.

[8]  T. Windahl,et al.  Two years' experience with photodynamic therapy of bladder carcinoma. , 1993, British journal of urology.

[9]  Gerald G. Miller,et al.  Biodistribution of Photofrin II® and 5‐Aminolevulinic Acid‐Induced Protoporphyrin IX in Normal Rat Bladder and Bladder Tumor Models: Implications for Photodynamic Therapy , 1998, Photochemistry and photobiology.

[10]  D. Jocham,et al.  Long-term experience with integral photodynamic therapy of TIS bladder carcinoma. , 1989, Ciba Foundation symposium.

[11]  C. Riedl,et al.  Intravesical electromotive drug administration technique: preliminary results and side effects. , 1998, The Journal of urology.

[12]  M. Snell,et al.  Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. , 1976, The Journal of urology.

[13]  N. Miyoshi,et al.  Photoradiation therapy of bladder tumors. , 1983, The Journal of urology.

[14]  Sequential whole bladder photodynamic therapy treatments: A preclinical study. , 1997, Urologic oncology.

[15]  P. Okunieff,et al.  Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. , 1997, Urology.

[16]  L. Baert,et al.  Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. , 1995, Urology.

[17]  Luc Baert,et al.  Initial evaluation of whole bladder wall photodynamic therapy after intravesical ALA sensitization for carcinoma in situ of the bladder , 1997, European Conference on Biomedical Optics.

[18]  T. Wieman,et al.  Complications of whole bladder dihematoporphyrin ether photodynamic therapy. , 1989, The Journal of urology.

[19]  A. J. MacRobert,et al.  Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. , 1998, British Journal of Cancer.

[20]  S. C. Chang,et al.  Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes. , 1996, The Journal of urology.

[21]  M. Hudson.  When intravesical measures fail. Indications for cystectomy in superficial disease. , 1992, The Urologic clinics of North America.

[22]  S. C. Chang,et al.  Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. , 1996, The Journal of urology.

[23]  R. Muller,et al.  Plasma Lignocaine Concentration following Nebulization for Awake Intubation , 1997, Anaesthesia and intensive care.

[24]  Hasan Mukhtar,et al.  Phthalocyanine Photodynamic Therapy: Disparate Effects of Pharmacologic Inhibitors on Cutaneous Photosensitivity and on Tumor Regression , 1997, Photochemistry and photobiology.

[25]  R. Baumgartner,et al.  Integral photodynamic treatment of refractory superficial bladder cancer. , 1995, The Journal of urology.

[26]  C. Orton,et al.  The Radiation Biology of the Vascular Endothelium , 1997 .

[27]  P. Okunieff,et al.  Phase I trial of photo dynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder , 1997 .

[28]  U. Nseyo,et al.  Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. , 1998, The Journal of urology.

[29]  R. Babayan,et al.  Carcinoma in situ of the bladder , 1983, World Journal of Urology.

[30]  D. Lamm,et al.  Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. , 1986, The Journal of urology.

[31]  N. Miyoshi,et al.  Integral laser photodynamic treatment of refractory multifocal bladder tumors. , 1991, The Journal of urology.

[32]  K. Koshida,et al.  Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder. , 1995, British Journal of Cancer.

[33]  H Stepp,et al.  Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias. , 1995, Urologia internationalis.